This week, we’re reading about Food and Drug Administration regulatory changes around drugmaker factories, research on urban pharmacy deserts, and pharmacists’ role in encouraging GLP-1 patient adherence, among other topics.
- Endpoints News: FDA proposes to streamline registration of drugmakers' foreign and US factories
- Becker’s Hospital Review: CDC flips the script on where pharmacy deserts actually are: 5 notes
- Managed Healthcare Executive: Trade group for transparent PBMs has changed its name
- Pharmacy Times: Pharmacists Can Help Patients Navigate GLP-1 Access, Affordability, and Long-Term Use
- The Seattle Times: Health Insurance Giants Are Fighting Efforts to Break Them Up
- WJAC: 'Encouraging milestone:' Pa budget language could restore Martella's PBM network access
NCPA
